April 16, 2020 — Intelerad Medical Systems announced that the U.S. Food and Drug Administration (FDA) has cleared its InteleConnect EV solution for diagnostic image review on a range of mobile devices.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now